🟢 HCW Biologics Inc is trading 15.3% up today on a technical rebound following a dilution-driven selloff

HCW Biologics Inc is trading 15.3% up today at $1.36 as the stock stages a technical rebound following a sharp multi-day slide.

• The recent downward pressure was primarily driven by investor concerns regarding potential dilution from a recent private placement.
• Market participants appear to be bargain hunting as offering-related selling pressure subsides, despite broader indices trading flat to slightly lower.
• The move is characterized as a technical correction rather than a reaction to fresh fundamental news or macro headlines.